|
European Website
|
|
Inhibitory Effects of Raw-Extract Centella asiatica (RECA) on Acetylcholinesterase, Inflammations, and Oxidative Stress Activities via In Vitro and In Vivo
Molecules2020, 25(4):892
Asiaticoside, Madecassoside, Asiatic acid and Madecassic acid were purchased from ChemFaces
Ginger extract and its compound, 6-shogaol, attenuates painful diabetic neuropathy in mice via reducing TRPV1 and NMDAR2B expressions in the spinal cord
J Ethnopharmacol.2020, 249:112396
6-Shogaol was purchased from ChemFaces
Composition for preventing or treating neurological and mental disorders, containing syringaresinol
United States Patent Application2020, 20200038363
Syringaresinol was purchased form ChemFaces
Evaluation of Anti-inflammatory Efficacy of RA-V: a Natural Cyclopeptide
Appl Biochem Biotechnol.2020, 190(2):732-744
RA-V was purchased from ChemFaces
Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species
Molecules.2020, 25(3):734
Skullcapflavone II, Nobiletin and Tangeretin were purchased from ChemFaces
Aqueous extract of Forsythia viridissima fruits: Acute oral toxicity and genotoxicity studies
J Ethnopharmacol.2020, 249:112381
Arctiin, Arctigenin and Matairesinol were purchased from ChemFaces
Development of an ultra‐high‐performance liquid chromatography coupled with triple quadrupole mass spectrometry method for comparative pharmacokinetics of six triterpenoids in rat plasma and application to different forms of Phytolacca acinosa
J Sep Sci.2020, 201901140
Esculentoside H, Esculentoside T, Esculentoside A, Esculentoside B, Phytolaccagenic acid and Phytolaccagenin were provided by ChemFaces
Subunit-specific effects of poricoic acid A on NMDA receptors
Pharmacological Reports2020, 1-9
Poricoic acid A was obtained from ChemFaces
